BMS-936558
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BMS-936558, covering 2017-03-22 to 2019-07-26. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Biomarker Study (BMS-936558) [Phase 1]